Data / Drug companies / Injection, solution
Companies that list injection, solution products: 373 companies and 5,349 products in the FDA NDC directory
The FDA National Drug Code Directory lists 5,349 products that are injection, solution products from 373 companies. The ten largest listers hold 39.6% of them, and the newest started marketing on November 3, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies
- 373
- Products
- 5,349
- Drugs by generic name
- 1,038
- Main marketing category
- Generic drugs (ANDA)
Companies that list injection, solution products
Ranked by number of products in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| ALK-Abello, Inc. | 424 | injection, solution | Biologics (BLA) | May 3, 2015 |
| Jubilant HollisterStier LLC | 335 | injection, solution | Biologics (BLA) | July 1, 2022 |
| Fresenius Kabi USA, LLC | 258 | injection, solution | Generic drugs (ANDA) | August 25, 2025 |
| Hospira, Inc. | 228 | injection, solution | Generic drugs (ANDA) | March 16, 2026 |
| HF Acquisition Co LLC, DBA HealthFirst | 210 | injection, solution | Generic drugs (ANDA) | July 10, 2026 |
| Eugia US LLC | 159 | injection, solution | Generic drugs (ANDA) | January 27, 2026 |
| Medical Purchasing Solutions, LLC | 141 | injection, solution | Generic drugs (ANDA) | July 28, 2026 |
| Baxter Healthcare Corporation | 136 | injection, solution | New drug applications (NDA) | October 19, 2026 |
| Eli Lilly and Company | 116 | injection, solution | New drug applications (NDA) | September 23, 2026 |
| Sagent Pharmaceuticals | 113 | injection, solution | Generic drugs (ANDA) | July 16, 2026 |
| Henry Schein, Inc. | 106 | injection, solution | Generic drugs (ANDA) | June 24, 2026 |
| Fresenius Kabi USA, LLC | 102 | injection, solution | Generic drugs (ANDA) | July 29, 2026 |
| Hikma Pharmaceuticals USA Inc. | 96 | injection, solution | Generic drugs (ANDA) | March 31, 2026 |
| Gland Pharma Limited | 91 | injection, solution | Generic drugs (ANDA) | September 30, 2026 |
| A-S Medication Solutions | 75 | injection, solution | Biologics (BLA) | January 22, 2026 |
| Meitheal Pharmaceuticals Inc. | 75 | injection, solution | Generic drugs (ANDA) | September 25, 2026 |
| Mylan Institutional LLC | 68 | injection, solution | Generic drugs (ANDA) | July 28, 2026 |
| ProPharma Distribution | 63 | injection, solution | Generic drugs (ANDA) | October 3, 2024 |
| American Regent, Inc. | 56 | injection, solution | Generic drugs (ANDA) | August 19, 2025 |
| B. Braun Medical Inc. | 49 | injection, solution | New drug applications (NDA) | October 1, 2026 |
| Icu Medical Inc. | 47 | injection, solution | New drug applications (NDA) | October 1, 2021 |
| Sandoz Inc | 47 | injection, solution | Generic drugs (ANDA) | October 12, 2026 |
| Novo Nordisk | 45 | injection, solution | Biologics (BLA) | August 11, 2026 |
| NorthStar RxLLC | 41 | injection, solution | Generic drugs (ANDA) | October 14, 2026 |
| Amneal Pharmaceuticals LLC | 37 | injection, solution | Generic drugs (ANDA) | December 23, 2025 |
| Fresenius Kabi USA, LLC | 37 | injection, solution | Generic drugs (ANDA) | July 28, 2026 |
| Somerset Therapeutics, LLC | 37 | injection, solution | Generic drugs (ANDA) | September 25, 2026 |
| Pfizer Laboratories Div Pfizer Inc | 36 | injection, solution | Biologics (BLA) | June 22, 2026 |
| Cardinal Health 107, LLC | 35 | injection, solution | Generic drugs (ANDA) | May 12, 2026 |
| Asclemed USA, Inc. | 34 | injection, solution | Generic drugs (ANDA) | November 2, 2022 |
| Dr. Reddy's Laboratories Inc. | 34 | injection, solution | Generic drugs (ANDA) | July 28, 2026 |
| Remedyrepack Inc. | 34 | injection, solution | Generic drugs (ANDA) | October 28, 2026 |
| Vantive US Healthcare LLC | 33 | injection, solution | Unapproved drugs for a shortage | November 7, 2024 |
| Caplin Steriles Limited | 32 | injection, solution | Generic drugs (ANDA) | June 25, 2026 |
| Zydus Pharmaceuticals USA Inc. | 32 | injection, solution | Generic drugs (ANDA) | July 2, 2026 |
| Baxter Healthcare Corporation | 31 | injection, solution | Generic drugs (ANDA) | September 18, 2026 |
| Genentech, Inc. | 31 | injection, solution | Biologics (BLA) | October 15, 2026 |
| Amgen, Inc | 29 | injection, solution | Biologics (BLA) | January 1, 2026 |
| Sportpharm LLC | 29 | injection, solution | Generic drugs (ANDA) | June 23, 2023 |
| Civica, Inc. | 28 | injection, solution | Generic drugs (ANDA) | August 1, 2026 |
| Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc. | 28 | injection, solution | Generic drugs (ANDA) | September 7, 2026 |
| Glenmark Pharmaceuticals Inc., USA | 26 | injection, solution | Generic drugs (ANDA) | July 28, 2026 |
| Siegfried Hameln GmbH | 26 | injection, solution | Drugs for further processing | October 19, 2026 |
| Bracco Diagnostics Inc | 24 | injection, solution | New drug applications (NDA) | January 1, 2026 |
| Hospira, Inc. | 24 | injection, solution | Generic drugs (ANDA) | April 8, 2025 |
| Lifestar Pharma LLC | 24 | injection, solution | Generic drugs (ANDA) | October 1, 2026 |
| Pharmacia & Upjohn Company LLC | 24 | injection, solution | New drug applications (NDA) | December 30, 2024 |
| Regeneron Pharmaceuticals, Inc. | 24 | injection, solution | Drugs for further processing | April 23, 2026 |
| WG Critical Care, LLC | 24 | injection, solution | New drug applications (NDA) | July 10, 2025 |
| Teva Parenteral Medicines, Inc. | 23 | injection, solution | Generic drugs (ANDA) | September 4, 2024 |
| Camber Pharmaceuticals, Inc. | 22 | injection, solution | Generic drugs (ANDA) | July 27, 2026 |
| Onesource Specialty Pharma Limited | 22 | injection, solution | Generic drugs (ANDA) | February 27, 2026 |
| Patheon Italia S.p.A. | 22 | injection, solution | Drugs for further processing | June 3, 2026 |
| Amneal Pharmaceuticals Private Limited | 21 | injection, solution | Generic drugs (ANDA) | October 20, 2026 |
| Sanofi-Aventis U.S. LLC | 20 | injection, solution | Biologics (BLA) | July 9, 2026 |
| Anthea Pharma Private Limited | 19 | injection, solution | Generic drugs (ANDA) | September 25, 2026 |
| Catalent Indiana, LLC | 19 | injection, solution | Drugs for further processing | January 1, 2025 |
| Avenacy, LLC | 18 | injection, solution | Generic drugs (ANDA) | August 15, 2026 |
| Baxter Healthcare Corporation | 18 | injection, solution | Generic drugs (ANDA) | September 11, 2026 |
| Piramal Critical Care Inc | 18 | injection, solution | Generic drugs (ANDA) | July 8, 2024 |
| Resilience US, LLC | 18 | injection, solution | Drugs for further processing | August 15, 2025 |
| BSP Pharmaceuticals S.p.A. | 17 | injection, solution | Drugs for further processing | September 22, 2026 |
| Curium US LLC | 17 | injection, solution | New drug applications (NDA) | March 31, 2022 |
| Eli Lilly Italia Spa | 17 | injection, solution | Drugs for further processing | February 3, 2025 |
| Exela Pharma Sciences, LLC | 16 | injection, solution | New drug applications (NDA) | December 12, 2023 |
| Sandoz Inc | 16 | injection, solution | Biologics (BLA) | October 26, 2026 |
| Vifor (International) Inc. | 16 | injection, solution | Biologics (BLA) | November 1, 2021 |
| Xellia Pharmaceuticals USA LLC | 16 | injection, solution | Generic drugs (ANDA) | August 1, 2023 |
| Armas Pharmaceuticals Inc. | 15 | injection, solution | Generic drugs (ANDA) | September 15, 2026 |
| Hikma Pharmaceuticals USA Inc. | 15 | injection, solution | Generic drugs (ANDA) | July 8, 2026 |
| Zydus Lifesciences Limited | 15 | injection, solution | Generic drugs (ANDA) | July 2, 2026 |
| Fosun Pharma USA Inc. | 14 | injection, solution | Generic drugs (ANDA) | July 29, 2026 |
| GE Healthcare Inc. | 14 | injection, solution | New drug applications (NDA) | September 30, 2026 |
| BluePoint Laboratories | 13 | injection, solution | Generic drugs (ANDA) | April 7, 2025 |
| Hepalink USA Inc. | 13 | injection, solution | Generic drugs (ANDA) | March 15, 2023 |
| Italfarmaco SpA | 13 | injection, solution | Generic drugs (ANDA) | November 10, 2025 |
| Merck Sharp & Dohme LLC | 13 | injection, solution | Biologics (BLA) | September 19, 2025 |
| Mylan Institutional LLC | 13 | injection, solution | Generic drugs (ANDA) | August 31, 2026 |
| Novo Nordisk Production Belgium SA | 13 | injection, solution | Drugs for further processing | January 1, 2025 |
| Septodont, Inc. | 13 | injection, solution | Generic drugs (ANDA) | March 19, 2026 |
| Ucb, Inc. | 13 | injection, solution | Biologics (BLA) | March 1, 2025 |
| Apotex Corp. | 12 | injection, solution | Generic drugs (ANDA) | May 9, 2025 |
| Becton Dickinson and Company | 12 | injection, solution | Generic drugs (ANDA) | November 14, 2025 |
| Biocon Biologics Inc. | 12 | injection, solution | Biologics (BLA) | November 3, 2026 |
| Bpi Labs LLC | 12 | injection, solution | Generic drugs (ANDA) | September 14, 2026 |
| Novocol Pharmaceutical of Canada, Inc. | 12 | injection, solution | Authorized generics (NDA) | January 8, 2020 |
| Slate Run Pharmaceuticals, LLC | 12 | injection, solution | Generic drugs (ANDA) | October 31, 2024 |
| XGen Pharmaceuticals DJB, Inc. | 12 | injection, solution | Generic drugs (ANDA) | June 24, 2025 |
| Accord Healthcare Inc. | 11 | injection, solution | Generic drugs (ANDA) | August 4, 2026 |
| Alembic Pharmaceuticals Inc. | 11 | injection, solution | Generic drugs (ANDA) | April 15, 2026 |
| AstraZeneca Pharmaceuticals LP | 11 | injection, solution | Biologics (BLA) | April 30, 2026 |
| Novadoz Pharmaceuticals LLC | 11 | injection, solution | Generic drugs (ANDA) | July 28, 2026 |
| Qilu Pharmaceutical Co., Ltd. | 11 | injection, solution | Generic drugs (ANDA) | October 28, 2025 |
| AbbVie Inc. | 10 | injection, solution | Drugs for further processing | June 12, 2026 |
| Avyxa Pharma, LLC | 10 | injection, solution | New drug applications (NDA) | October 29, 2026 |
| Celltrion USA, Inc. | 10 | injection, solution | Biologics (BLA) | April 13, 2026 |
| Cordavis Limited | 10 | injection, solution | Biologics (BLA) | October 10, 2025 |
| Natco Pharma USA LLC | 10 | injection, solution | Generic drugs (ANDA) | July 2, 2026 |
| Patheon Manufacturing Services LLC | 10 | injection, solution | Drugs for further processing | October 23, 2025 |
| Biogen Inc. | 9 | injection, solution | Biologics (BLA) | March 27, 2026 |
Drugs most often listed
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.